Drug giants fail to name compounds in trial database

  • Wadman M
N/ACitations
Citations of this article
6Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

An international group of medical editors is challenging several leading pharmaceutical companies, saying that their reporting of clinical trials is deliberately incomplete.The International Committee of Medical Journal Editors made their complaint in an editorial in The New England Journal of Medicine, published online on 23 May. EXCLUSION: Focus on reporting trials

Cite

CITATION STYLE

APA

Wadman, M. (2005). Drug giants fail to name compounds in trial database. Nature, 435(7042), 548–548. https://doi.org/10.1038/435548b

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free